Kerridge BT, Pickering RP, Saha TD, Ruan WJ, Chou SP, Zhang H, Jung J, Hasin DS (2017) Prevalence, sociodemographic correlates and DSM-5 substance use disorders and other psychiatric disorders among sexual minorities in the United States. Drug Alcohol Depend 170:82–92. https://doi.org/10.1016/j.drugalcdep.2016.10.038
Papazisis G, Tzachanis D (2014) Pregabalin’s abuse potential: a mini review focusing on the pharmacological profile. Int J Clin Pharmacol Ther 52(8):709–716. https://doi.org/10.5414/CP202118
Drug Enforcement Administration (2005) Department of Justice schedules of controlled substances: placement of pregabalin into schedule V. Final rule. Fed Regist 70(144):43633
Lancia M, Gambelunghe A, Gili A, Bacci M, Aroni K, Gambelunghe C (2020) Pregabalin abuse in combination with other drugs: monitoring among methadone patients. Front Psychiatry 10:1022
Bastiaens L, Galus J, Mazur C (2016) Abuse of gabapentin is associated with opioid addiction. Psychiatr Q 87(4):763–767
Gabr AA (2019) Prevalence and risk factors of pregabalin misuse among patients with substance use disorder. Al-Azhar Assiut Med J 17(4):393
King MA (2018) Pregabalin and gabapentin associated with depression and suicidal ideation. BMJ 363:k4979
Dean A, Sullivan KM, Soe MM (2013) OpenEpi: Open Source Epidemiologic Statistics for Public Health. Version 2.3.1
First MB, Spitzer RL, Gibbon M, Williams JB (2002) Structured Clinical Interview for DSM-IV-TR axis I disorders, research version, patient edition. SCID-I/P, New York, pp 94–91
El Missiry A, Sorour A, Sadek A, Fahy TA, Mawgoud M, Asaad T (2003) Homicide and psychiatric illness: an Egyptian study [MD thesis]. Faculty of Medicine, Ain Shams University, Cairo
First M, Gibbon M, Spitzer R (1997) Structured Clinical Interview for DSM-IV axis II personality disorders (SCID-II). American Psychiatric Press; Inc
Zimmerman M, Pfohl B, Coryell W, Stangl D, Corenthal C (1988) Diagnosing personality disorder in depressed patients: a comparison of patient and informant interviews. Arch Gen Psychiatry 45:733–737
Hatata H, Khalil A, Asaad T (2003) Dual diagnosis in substance use disorders a study in Egyptian sample. Unpublished MD thesis. Institute of psychiatry .Ain shams university, Egypt
Beck AT, Steer RA, Carbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8(1):77–100
Beck, A. T., & Beamesderfer, A. (1974). Assessment of depression: the depression inventory. S. Karger.
Abdel-Khalek AM (1998) Internal consistency of an Arabic adaptation of the Beck Depression Inventory in four Arab countries. Psychol Rep 82(1):264–266
Beck AT, Steer RA, Ranieri WF (1988) Scale for suicide ideation: psychometric properties. J Clin Psychol 44:499–505
Hamilton M (1959) Hamilton Anxiety Rating Scale. Brit J Med Psychol 32:50–55
Maier W, Buller R, Philipp M, Heuser I (1988) The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord 14(1):61–68
Thompson E (2015) Hamilton rating scale for anxiety (HAM-A). Occup Med 65(7):601
Fateem L (1998) Arabic manual of Hamilton anxiety scale translated and adapted by Lotfy Fateem. The Anglo-Egyptian Bookshop, Egypt
IBM (2020) IBM SPSS Statistics for Windows, Version 27. IBM Corp, Armon http://www-01.ibm.com/support/docview.wss?uid=swg27049428
Lai HMX, Cleary M, Sitharthan T, Hunt GE (2015) Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug Alcohol Depend 154:1–13
Terracciano A, Löckenhoff CE, Crum RM, Bienvenu OJ, Costa PT (2008) Five-factor model personality profiles of drug users. BMC Psychiatry 8(1):1–10
Tandon VR, Mahajan V, Gillani ZH, Mahajan A (2013) Pregabalin-induced self-harm behavior. Indian J Pharmacol 45(6):638
Kienast T, Stoffers J, Bermpohl F, Lieb K (2014) Borderline personality disorder and comorbid addiction: epidemiology and treatment. Deutsches Ärzteblatt Int 111(16):280
Evren C, Kural S, Erkiran M (2006) Antisocial personality disorder in Turkish substance dependent patients and its relationship with anxiety, depression and a history of childhood abuse. Israel J Psychiatry Relat Sci 43(1):40
Parmar A, Kaloiya G (2018) Comorbidity of personality disorder among substance use disorder patients: a narrative review. Indian J Psychol Med 40(6):517–527
Sayed SM, Ahmad HEK, Sayied NE, El-Aziz A, Mohamed A (2020) Effect of psycho-educational program on depression among drug addict patients at Assiut University Hospital. Assiut Sci Nurs J 8(20):45–55
Mohamed II, Ahmad HEK, Hassaan SH, Hassan SM (2020) Assessment of anxiety and depression among substance use disorder patients: a case-control study. Middle East Curr Psychiatry 27:1–8
Singh D, Yadav JS, Jamuda BK, Singh P (2019) Oral pregabalin as premedication on anxiolysis and stress response to laryngoscopy and endotracheal intubation in patients undergoing laparoscopic cholecystectomy: a randomized double-blind study. Anesth Essays Res 13(1):97
Fahmy MT, Haggag WL, Mohamed KA, Baalash AA (2015) A study of the personality traits and the level of anxiety in suicidal polydrug users. Egyptian J Psychiatry 36(2):106
Rodríguez-Cintas L, Daigre C, Braquehais MD, Palma-Alvarez RF, Grau-López L, Ros-Cucurull E et al (2018) Factors associated with lifetime suicidal ideation and suicide attempts in outpatients with substance use disorders. Psychiatry Res 262:440–445
Philips B, Wennberg P, Konradsson P, Franck J (2018) Mentalization-based treatment for concurrent borderline personality disorder and substance use disorder: a randomized controlled feasibility study. Eur Addict Res 24(1):1–8
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Disclaimer:
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.springeropen.com/)